The US Food and Drug Administration (FDA) has warned an oncology drug company for repeatedly overstating the efficacy of its drug in advertisements while failing to adequately disclose the associated ...
Simtra Biopharma Solutions recieved a warning letter from the FDA after an inspection uncovered several issues at the CDMO’s production plant in Halle, Germany. The rebuke from the U.S. regulatory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results